Armistice Capital »

Sensient Technologies Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Sensient Technologies Corporation (SXT) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Sensient Technologies Corporation

Tip: Access up to 7 years of quarterly data

All positions including Sensient Technologies Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensient Technologies Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $20M 267k 74.19
2024-03-31 $26M 379k 69.19

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Sensient Technologies Corporation

BlackRock
BlackRock
Winder Pte
Vanguard Group
Henderson Group
State Street Corporation
Nordea Investment Management Ab
Dimensional Fund Advisors
Champlain Investment Partners
Geode Capital Management
Snyder Capital Management
First Trust Advisors
Charles Schwab Investment Management
Btim
Northern Trust

View all funds holding Sensient Technologies Corporation